title: The dilemma of antimicrobial treatment of Shiga toxin-producing Escherichia coli.
authors.affiliation: From the *Department of Emergency Pediatrics, †Department of Pediatric Infectious Diseases, and ‡Department of Pediatrics A, Schneider Children's Medical Center, Petach Tikva; and §Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Meirav
authors.initials: M
authors.lastname: Mor
authors.forename: Shai
authors.initials: S
authors.lastname: Ashkenazi
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000494:pharmacology; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D006463:Hemolytic-Uremic Syndrome / Q000382:microbiology*; D006801:Humans; D022621:Shiga Toxin / Q000096:biosynthesis; D054323:Shiga-Toxigenic Escherichia coli / Q000187:drug effects / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D022621:Shiga Toxin